FluMist approved for self-administration in the US - astrazeneca.com
WEB3 days ago · FluMist has been approved in the US as the only self-administered influenza vaccine.FluMist, a needle-free nasal spray, was approved to be self-administered by adults up to 49 years of age or administered by a parent/caregiver to individuals 2-17 years of age. 1. The approval by the US Food and Drug Administration (FDA) was based on a comprehensive submission, which included results from a ...
FDA approves first flu vaccine that can be self-administered at …
WEB2 days ago · Link Copied! The FDA approved FluMist as the first flu vaccine that can be self-administered at home. Sarah Silbiger/Getty Images. The US Food and Drug Administration on Friday approved the first ...
FDA approves first self-administered flu vaccine spray - CBS News
WEB2 days ago · The FDA approved AstraZeneca's FluMist flu vaccine spray for self-administered use at home. ... Alexander Tin is a digital reporter for CBS News based in the Washington, D.C. bureau. He covers the ...
FDA approves first at-home flu vaccine in U.S., a nasal spray
WEB2 days ago · Sept. 20, 2024. Senior Writer, Infectious Diseases. The Food and Drug Administration on Friday approved AstraZeneca’s bid to allow its nasal spray influenza vaccine, FluMist, to be sold for home ...
AZ's FluMist wins FDA nod as first self-administered flu vaccine
WEB2 days ago · With FDA nod, AstraZeneca's FluMist becomes first self-administered flu vaccine. By Fraiser Kansteiner Sep 20, 2024 3:24pm. AstraZeneca Flumist Influenza influenza vaccine. AstraZeneca has just ...
FLUMIST approved for self-administration in the US
WEB2 days ago · Iskra Reic, Executive Vice President, Vaccines and Immune Therapies, AstraZeneca, said: “The approval of FLUMIST for self-administration is an important step forward in making vaccines more ...
FDA Approves Nasal Spray Influenza Vaccine for Self- or Caregiver ...
WEB3 days ago · FluMist is approved for the prevention of influenza disease caused by influenza virus subtypes A and B in individuals 2 through 49 years of age. FluMist is sprayed into the nose and has been used ...
US FDA approves AstraZeneca's flu vaccine for self-administration
WEB3 days ago · Sept 20 (Reuters) - The U.S. Food and Drug Administration said on Friday it has approved AstraZeneca's (AZN.L), opens new tab nasal spray flu vaccine for self-administration, making it the first ...
FLUMIST® QUADRIVALENT (Influenza Vaccine Live ... - AstraZeneca US
WEBSep 23, 2022 · AstraZeneca announces FLUMIST ® QUADRIVALENT (Influenza Vaccine Live, Intranasal) doses are now available in the US for the 2022-2023 influenza season. FLUMIST QUADRIVALENT, the only Food and Drug Administration (FDA)-approved nasal-spray flu vaccine, is indicated for people ages 2 through 49. 1.
US Food and Drug Administration accepts for review AstraZeneca…
WEBOct 24, 2023 · AstraZeneca’s Supplemental Biologics License Application (sBLA) for the approval of a self- or caregiver-administered option for FluMist Quadrivalent, a needle-free nasal spray, has been accepted for review by the US Food and Drug Administration (FDA). If approved, FluMist will be the first flu vaccine available to be self-administered by eligible patients or administered by caregivers ...